Axcella
is a biotechnological company that develops medicines for metabolic dysregulation... Read moreAxcella
is a biotechnological company that develops medicines for metabolic dysregulation... Read more
News
Dec 05, 2023
The Business Journals
Axcella: Flagship spinout Axcella collapses, leaving future of its long Covid drug uncertain
Sep 14, 2023
Business Wire
Press Release: Axcella : Axcella Announces Reverse Stock Split Effective September 19, 2023
Sep 11, 2023
MarketScreener
Axcella: Axcella Health : Submission of Matters to a Vote of Security Holders - Form 8-K
Aug 30, 2023
MedicalMarketing& Media
Axcella: Axcella granted patent for long COVID fatigue treatment
Aug 08, 2023
Americanbankingnews
Axcella: Axcella Health Inc. (NASDAQ:AXLA) to Post Q1 2024 Earnings of ($0.05) Per Share, HC Wainwright Forecasts
Aug 04, 2023
MarketScreener
Axcella: Axcella Health : Shareholder Director Nominations - Form 8-K
Aug 03, 2023
BioSpace
Axcella: Axcella Reports Second Quarter Financial Results and Provides Business Update - August 3, 2023
May 04, 2023
Benzinga
Axcella: Axcella Health Q1 EPS $(0.05) Beats $(0.16) Estimate
May 04, 2023
BioSpace
Axcella: Axcella Reports First Quarter 2023 Financial Results and Provides Business Update
Apr 17, 2023
Benzinga
Axcella: Axcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023
Axcella Competitors
1
2
3
4
5
6
7
8
9
10